Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | CETP | P11597 | 3/20 | 0.35 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.35 |
| ▸ | GMNN | O75496 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.35 |
| ▸ | CCR6 | P51684 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | UBE2N | P61088 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11410792 | 0.91 | USP2 (0.46) | USP2DGKALMNAMEN1KMT2A | |
| SCHEMBL18763294 | 0.91 | USP2 (0.46) | USP2DGKALMNAMEN1KMT2A | |
| SCHEMBL1978647 | 0.91 | USP2 (0.46) | USP2DGKALMNAMEN1KMT2A | |
| SCHEMBL8106179 | 0.91 | USP2 (0.46) | USP2DGKALMNAMEN1KMT2A | |
| SCHEMBL9568707 | 0.86 | DGKA (0.53) | DGKALMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL9321967 | 0.86 | — | — | |
| SCHEMBL16227302 | 0.82 | FFAR1 (0.38) | ALDH1A1MAPTSPHK1FAAHTSHR | |
| SCHEMBL6685717 | 0.81 | LMNA (0.38) | LMNAALDH1A1THRB | |
| SCHEMBL27637092 | 0.77 | TSHR (0.42) | LMNAMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL5934074 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080254508-A1 | TYPE I POLYKETIDE SYNTHASE EXTENDER UNITS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-16 | — | — | US | claimed |
| US-4504474-A | Synthetic phosphoglycerides possessing platelet activating properties | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1985-03-12 | — | — | US | claimed |
| WO-2024127733-A1 | CURABLE COMPOSITION, POLARIZING FILM, OPTICAL FILM, AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2024-06-20 | — | — | WO | disclosed |
| WO-2024127721-A1 | CURABLE RESIN COMPOSITION, POLARIZING FILM, MULTILAYER OPTICAL FILM, AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2024-06-20 | — | — | WO | disclosed |
| WO-2024127722-A1 | CURABLE RESIN COMPOSITION, POLARIZING FILM, MULTILAYER OPTICAL FILM AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2024-06-20 | — | — | WO | disclosed |
| WO-2023234100-A1 | POLARIZING PLATE WITH RETARDATION LAYER AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2023-12-07 | — | — | WO | disclosed |
| CN-116945619-A | Method for producing optical laminate | 日东电工株式会社 | 2023-10-27 | — | — | CN | disclosed |
| EP-3901966-B1 | CONDUCTIVE ADHESIVE SHEET, LAMINATE, AND HEATING DEVICE | LINTEC CORP (JP) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023157405-A1 | OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023157404-A1 | PRODUCTION METHOD FOR POLARIZING FILM | 日東電工株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023157406-A1 | OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE | 日東電工株式会社 | 2023-08-24 | — | — | WO | disclosed |
| US-6511677-B1 | Oral drug delivery system; such as octadeca-2,4-dienoyl-polyethylene glycol-succinic acid with covalently bound ligand that targets intestine mucosal tissue | ORASOMOL TECHNOLOGIES, INC. | 2003-01-28 | — | — | US | disclosed |
| US-6500453-B2 | DRUG DELIVERY | ORASOMOL TECHNOLOGIES, INC. | 2002-12-31 | — | — | US | disclosed |
| US-20020041861-A1 | Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom | ORASOMAL TECHNOLOGIES, INC. | 2002-04-11 | — | — | US | disclosed |
| US-6187335-B1 | DRUGS, POLYESTERETHER COPOLYMERS AND PHOSPHOLIPIDS | ORASOMAL TECHNOLOGIES, INC. | 2001-02-13 | — | — | US | disclosed |
| EP-1049759-A1 | NOVEL POLYMERIZABLE FATTY ACIDS, PHOSPHOLIPIDS AND POLYMERIZED LIPOSOMES THEREFROM | Orasomal Technologies, Inc. (US) | 2000-11-08 | — | — | EP | disclosed |
| WO-1999033940-A1 | NOVEL POLYMERIZABLE FATTY ACIDS, PHOSPHOLIPIDS AND POLYMERIZED LIPOSOMES THEREFROM | ORASOMAL TECHNOLOGIES, INC. (US) | 1999-07-08 | — | — | WO | disclosed |
| US-4551446-A | Use of synthetic phosphoglycerides possessing platelet activating properties as desensitizing agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1985-11-05 | — | — | US | disclosed |
| US-4504474-A | Synthetic phosphoglycerides possessing platelet activating properties | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1985-03-12 | — | — | US | disclosed |
| US-4329302-A | Synthetic phosphoglycerides possessing platelet activating properties | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1982-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020041861-A1 | Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom | SGMS1, SGMS2, PHOSPHO1 | USP2 2689/4885DGKA 120/4885LMNA 2418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.